期刊文献+

足叶乙苷长循环脂质体的小鼠代谢动力学研究 被引量:1

Pharmacokinetics of Etoposide Long-circulating Liposomes in Mice
原文传递
导出
摘要 目的研究足叶乙苷长循环脂质体的小鼠体内代谢动力学。方法采用HPLC测定血药浓度,考察脂质体在小鼠体内的代谢动力学行为。结果足叶乙苷线性范围为10.5~210μg.mL-1,回收率在90%以上,精密度符合要求。长循环脂质体的消除半衰期t1/2和AUC分别是注射剂的17和3.5倍。结论足叶乙苷长循环脂质体在小鼠体内的消除半衰期较长,能达到长循环目的。 OBJECTIVE To investigate in vivo pharmacokinetics of etoposide long-circulating liposomes in mice.METHODS Plasma concentration was determined by a validated HPLC assay.In vivo pharmacokinetic dynamic behavior of liposomes was analyzed.RESULTS The linear range of etoposide was 10.5-210 μg·mL^-1,recovery ratio was between 90% and 100%,and accuracy met the requirements.The elimination half-life and AUC of long-circulating liposomes were 17 and 3.5 times as injection preparations.CONCLUSION Etoposide long-circulating liposomes had long half-life of elimination,can achieve long-circulating profile.
出处 《中国药学杂志》 CAS CSCD 北大核心 2010年第16期1247-1250,共4页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30772790)
关键词 长循环脂质体 足叶乙苷 代谢动力学 long-circulating liposome etoposide pharmacokinetics
  • 相关文献

参考文献8

  • 1CONRAD R, I,EWANSKI, SIMON S. Pegylated liposomal adriamycin: a review of current and future applications [J].Research Focus, 1999, 2(12) : 473-477. 被引量:1
  • 2AISNER J, LEE E J. Etoposide: Current and future status[ J]. Cancer, 1991,67 (suppl) : 215. 被引量:1
  • 3LAKKIREDDY H R, RAKEStt K S, KRISHNA C, et al. Etoposide-incorporated tripahnitin nanoparticles with difference with different surface charge : formulation, characterization, radiolabeling, and biodistribution studies[J]. AAPS J, 2004, 6(3 ) : 1-10. 被引量:1
  • 4SENGUPTA S, TYAGI P, CHANDRA S, et al. Etoposide encapsulated in positively charged liposomes : phaarmcokinetic studies in mice and formulation stability studies [ J ]. Phamacol Res, 2000, 42(5) :459-464. 被引量:1
  • 5VALDUGA C J,FERNANDES D C,LOPRETE A C,et al. Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide [ J ]. J Pharm Pharmacol,2003,55(12):1615-1622. 被引量:1
  • 6时军,程怡,陈伟鸿,宿央央.足叶乙苷长循环脂质体的制备及血浆中稳定性研究[J].广州中医药大学学报,2009,26(3):270-273. 被引量:9
  • 7MAEDA H, FANG J, INUZUKI T, et al. Vascular permeability enhancement in solid tumors: various factors, mechanisms involved and its implications [ J ] . lnt lmmumpharmacol, 2003,3 (3) :319. 被引量:1
  • 8AWASHI V D, GARCIA D, GOINS B, et al. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits[J]. Inter J Pharm, 2003, 253 ( 1 ) : 121-132. 被引量:1

二级参考文献7

  • 1Hande K R. Etoposide: Four decades of development of a topoisomerase Ⅱ inhibitor [J]. Eur J Cancer, 1998, 34: 1514. 被引量:1
  • 2Smit E F, Carney D N, Harford P, et al. A phase Ⅱ study of oral etoposide in elderly patients with small cell lung cancer [ J ]. Thorax, 1989, 44: 631. 被引量:1
  • 3Hande K R. Etoposide pharmacology [J]. Semin Oncol, 1992, 19 (Suppl 13) : 3. 被引量:1
  • 4Sengupta S, Tyagi P, Chandra S, et al. Etoposide encapsulated in positively charged liposomes: pharnaacokinetic studies in mice and formulation stability studies [ J]. Phamacological Res, 2000, 42 (5): 459. 被引量:1
  • 5Daemen T, Regts J, Meesters M, et al. Toxicity of doxorubicin entrapped within long-circulating liposomes [ J ]. J Control Release, 1997, 44: 1. 被引量:1
  • 6Pons M, Fomdada M, Estelrich J. Liposomes obtained by the ethanol injection method [J]. Int J Pharm, 1993, 95: 51. 被引量:1
  • 7Allen T M. Long-circulating (sterieally stabilized ) liposomes for targeted drug delivery [J]. Trends Pharm Sci, 1994, 15: 215. 被引量:1

共引文献8

同被引文献30

  • 1ThambTi,ParkJH.RecentAdvancesinShell-SheddableNanopar-ticlesforCancerTherapy[J].JournalofBiomedicalNanotechnol-ogy,2014,10(9):1-22. 被引量:1
  • 2AkbarzadehA,Rezaei-SadabadyR,DavaranS,etal.Liposome:classification,preparation,andapplications[J].NanoscaleResLett,2013,8(1):102-111. 被引量:1
  • 3KraftJC,FreelingJP,WangZ,etal.EmergingResearchandClini-calDevelopmentTrendsofLiposomeandLipidNanoparticleDrugDeliverySystems[J].JPharmSci,2014,103(1):29-52. 被引量:1
  • 4PiJ,LiuZ,ShuL,etal.TissuedistributionstudyofsalvianolicacidBlong-circulatingliposomesinmicebyUPLC-MS/MSdeter-mination[J].PakJPharmSci,2015,28(1):213-220. 被引量:1
  • 5ShaviGV,ReddyMS,RaqhavendraR,etal.PEGylatedliposomesofanastrozoleforlong-termtreatmentofbreastcancer:invitroandinvivoevaluation[J].JLiposomeRes,2015[Epubaheadofprint]. 被引量:1
  • 6ZhouJ,ZhaoWY,MaX,etal.Theanticancerefficacyofpaclitaxelliposomesmodifiedwithmitochondrialtargetingconjugateinresist-antlungcancer[J].Biomaterials,2013,34(14):3626-3638. 被引量:1
  • 7AbuLilaAS,NawataK,ShimizuT,etal.Useofpolyglycerol(PG),insteadofpolyethyleneglycol(PEG),preventsinductionoftheacceleratedbloodclearancephenomenonagainstlong-circu-latingliposomesuponrepeatedadministration[J].IntJPharm,2013,456(1):235-242. 被引量:1
  • 8YangQ,MaY,ZhaoY,etal.Accelerateddrugreleaseandclear-anceofPEGylatedepirubicinliposomesfollowingrepeatedinjec-tions:anewchallengeforsequentiallow-dosechemotherapy[J].IntJNanomedicine,2013,8:1257-1268. 被引量:1
  • 9吴燕,吴诚,梅兴国,吕万良.盐酸表柔比星长循环热敏脂质体的处方优化及体外释药考察[J].中国药学杂志,2010,45(9):677-681. 被引量:8
  • 10赵利刚,杨清敏,杨光丽,王栋海,严守升,张慧,王晶翼.酒石酸长春瑞滨长循环脂质体的包封率测定及药效研究[J].中国药科大学学报,2010,41(6):508-512. 被引量:7

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部